IGC Pharma
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $328 | $265 | $317 | $350 |
Gross Profit | 61 | 48 | 55 | 44 |
EBITDA | -1,931 | -2,727 | -2,344 | -662 |
EBIT | -2,784 | -2,402 | -726 | |
Net Income | -2,046 | -2,936 | -2,402 | -726 |
Net Change In Cash | 328 | 265 | 317 | 350 |
Free Cash Flow | -1,248 | -1,355 | -1,393 | -1,235 |
Cash | 377 | 331 | 207 | 900 |
Basic Shares | 109,490 | 100,331 | 95,038 | 95,038 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $1,186 | $1,271 | $1,345 | $911 |
Gross Profit | 352 | 619 | 733 | -158 |
EBITDA | -6,490 | -6,503 | -12,363 | -10,849 |
EBIT | -6,548 | -7,121 | -13,000 | -11,506 |
Net Income | -6,548 | -7,121 | -13,000 | -11,506 |
Net Change In Cash | 1,186 | 1,271 | 1,345 | 911 |
Free Cash Flow | -6,107 | -5,277 | -5,714 | -7,666 |
Cash | 207 | 405 | 1,198 | 3,196 |
Basic Shares | 95,038 | 76,517 | 58,840 | 52,576 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.02 |
2026-06-30 | -$0.03 |
2026-03-31 | -$0.02 |
2025-12-31 | -$0.02 |